Judy Dewinter
Judy was appointed chair in May 2019.
She had a successful career with the world’s first electronic brokerage firm, Instinet, culminating in a board role leading its European equities division.
In 2003, Judy left her job when she started treatment for the blood cancer multiple myeloma. Since then, she has worked tirelessly to improve the treatment for, and care of, myeloma patients, chairing the board of Myeloma UK and then becoming its president. She is also a patient representative on various boards and advisory groups and was previously the lead governor at the Royal Free London NHS Foundation Trust (RFL), where she has been treated for many years.
She said: “I am delighted to be leading the Royal Free Charity to help the RFL move further and faster, investing in the services provided to patients, supporting the dedicated and hardworking Royal Free staff and funding research.”
